Sunil Healthcare (BOM:537253) Other Financing: ₹0.0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:537253 Sunil Healthcare Ltd BOM:537253
59 GF Score
Price ₹67.30
GF Value ₹70.88
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Sunil Healthcare Other Financing?

Sunil Healthcare BOM:537253 -1.75% 59 Other Financing is ₹0.0 Mil as of Mar. 2026. GuruFocus rates BOM:537253 with a GF Score™ of 59/100 and a GF Value™ of ₹70.88 (Fairly Valued). The stock has 7 warning signs investors should review.

Sunil Healthcare's Other Financing for the three months ended in Mar. 2026 was ₹0.0 Mil.

Sunil Healthcare's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.0 Mil.

Sunil Healthcare Other Financing Historical Data

* Premium members only.

The historical data trend for Sunil Healthcare's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunil Healthcare Other Financing Chart

Sunil Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -32.98 -40.03 -55.33 -62.32 -59.67

Sunil Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:537253
59GF Score
Sunil Healthcare Ltd BOM:537253
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunil Healthcare Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of ₹0.0 Mil mean?
Sunil Healthcare (BOM:537253) has a Other Financing of ₹0.0 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Sunil Healthcare and its competitors.
Is Sunil Healthcare's Other Financing too high?
Sunil Healthcare's current Other Financing is ₹0.0 Mil. Overall, Sunil Healthcare has a GF Score™ of 59/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sunil Healthcare's Other Financing compare to ZTS and UTHR?
Sunil Healthcare's Other Financing of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Drug Manufacturers company?
A good Other Financing depends on the Drug Manufacturers industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Sunil Healthcare and its competitors. Sunil Healthcare's current Other Financing is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunil Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sunil Healthcare (BOM:537253) is currently considered Fairly Valued. The stock's GF Value™ is ₹70.88, compared to a current price of ₹67.30 — trading 5.1% below its estimated fair value. The current Other Financing is ₹0.0 Mil. Sunil Healthcare's overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Sunil Healthcare (BOM:537253), the current Other Financing is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sunil Healthcare (BOM:537253) Overvalued in 2026?

Based on GuruFocus' analysis, Sunil Healthcare stock appears to be undervalued. The current stock price of ₹67.30 is trading 5.1% below its estimated GF Value™ of ₹70.88. GuruFocus considers Sunil Healthcare to be Fairly Valued.

Key valuation signals for BOM:537253:

  • Other Financing: ₹0.0 Mil
  • GF Value™: ₹70.88 vs. price of ₹67.30 (5.1% below fair value)
  • GF Score™: 59/100 with 7 warning signs

No single metric tells the full story. See the BOM:537253 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sunil Healthcare Business Description

Address 38E/252 - A, Vijay Tower, 3rd Floor, Opposite Panchsheel Commercial Complex, Shahpurjat, New Delhi, IND, 110049
Sunil Healthcare Ltd manufactures hard gelatin capsule shells that are used by pharmaceutical and food supplement companies. It operates in a single segment, that is, Empty Capsules. The company manufactures nine different sizes of capsules. Its products include BSE Free Capsules, Pearl Capsules, Liquid Fill Capsules, Stick Free Capsules, and Preservative Free Capsules. The company generates the majority of its revenue from India.
59GF Score

Get the complete analysis for BOM:537253

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹67.30
Price
₹70.88
GF Value